Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
NTRA
NATERA INC (Common Stock) โ€“ ticker 45E NTRA
$221.21
โ–ผ -3.27% 24H
6.9966.38125.77185.16244.552015-062018-032020-122023-092026-06

About

Natera Inc. is a diagnostics company specializing in advanced genetic testing services for patients, clinicians, and healthcare systems. The company focuses on analyzing cell-free DNA to support clinical decision-making across several key areas of medicine. Nateraโ€™s portfolio includes non-invasive prenatal tests that sโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees4,424
TickerNTRA

Statistics

Market Cap$31.57B
Revenue (TTM)$2.31B
Net Income-$208.2M
Net Margin-9.0%
EPS$-1.62
P/E-144.16
P/S12.40
P/B17.42
EV/EBITDA-112.71
ROE-15.0%
Dividend Yieldโ€”
Price$221.21

Data: Twelve Data ยท Revenue = mcap / P/S

NATERA INC (Common Stock) โ€“ ticker 45E (NTRA) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap